1.
Trends Biotechnol
; 35(7): 573-576, 2017 07.
Article
in English
| MEDLINE
| ID: mdl-28511937
ABSTRACT
Achieving consistency in standards of access to and quality of human induced pluripotent stem cells has lagged behind their use. In Europe, a network of academic and industrial partners has been established to overcome this challenge. The experience reveals the devil in the detail of worthy ambitions informing future efforts.